The Myth of Data Permanence

Data Really Isn’t Permanent Cyber specialists warn that once something appears on the Internet, it’s there forever. That’s probably truer for salacious photos of pop stars than it is for corporate or government data, though. In scientific communications, unless you collect data as it’s published, you may not be able to retrieve the information you want when you need it.
READ MORE

Dedicated Field Medical Metrics

Historically, Medical Affairs has primarily served a supportive role. Today, it’s becoming a strategic advantage. Filtering information and experts helps Field Medical teams reduce their preparation time up to an estimated 75 percent, to maximize valuable resources.
READ MORE

CITATION: PD-L1/PD-1 Inhibitors and Beyond

A peer-reviewed article that appeared in the Journal of Pharmacology and Clinical Research by David Segarnick, PhD and Heather Chien, M.S., explores the current and future landscape of immunotherapy compounds that use the body's own immune system to fight cancer, citing Medmeme data
READ MORE

Strategic Metrics Dedicated to Medical Affairs

Metrics that bridge the gap to Medical Affairs 2.0-Historically, decisions for the generation and placement of Medical Affairs data were based on experience and instinct simply because hard, objective information was not available and end-to-end metrics for evaluation simply did not exist. Medical Affairs is in the process of evolving from a traditional support role into a more strategic one that requires a dedicated set of data and analytics
READ MORE

PRESS: Harnessing the Unrivaled Power of Key Opinion Leaders

This month's Pharmaceutical Market Europe Magazine features a thought leadership article from Medmeme.  The article discusses the importance of Medical Affairs engaging thought leaders and KOLs early  - not waiting until phase III trials - to drive Share of Scientific Voice and successful launches.
READ MORE

Are You Being Heard?

Is it better for your scientific paper to appear in JAMA or the New England Journal of Medicine? Should you present your research at a specialty meeting like the Annual Meeting of the Society for Immunotherapy of Cancer or choose a more general conference like the American Society of Clinical Oncology (ASCO)? How you answer those questions affects the impact of your scientific dissemination – your ability to present information to key thought leaders and receive attention from the scientific community.
READ MORE

Never Gonna Give You Up

One thing that data providers are quickly finding out is that maintaining complete, compliant and updated information on Scientific Experts is hard, especially at an enterprise level for a Medical Affairs organization
READ MORE

PRESS: A World of Content, In Context

Medmeme has been featured this week in GEN – Genetic Engineering and Biotechnology News! An in-depth interview with Medmeme’s CEO, Mahesh Naithani, who describes the particular challenges the pharmaceutical industry has in terms of accessing the right data
READ MORE

Big data’s big potential

As the ocean of data gathered from research studies, wearables and medtech continues to spiral, the pharma industry is faced with a conundrum: what data are actually relevant, how can we access them easily and how do we draw insights from them?
READ MORE

Not all data is relevant

Not all data is relevant—in fact, most of it isn’t. Recognizing the fit between the data sources, the analytic tools, and the problem you want to solve is paramount.
READ MORE

Why Context Is Critical

Data without context can’t tell you about trends, can’t help you identify patterns and can’t help you make relative assessments to base your decisions on.
READ MORE

Data Normalization

We have previously discussed the challenging process of disambiguation and its importance to developing a high value database that easily yields trustworthy and consistent results. Yet despite all the complexity and work involved in disambiguation, it only gets you part of the way to clean and useful data. The other critical process is called normalization.
READ MORE

How is Disambiguation Done?

Disambiguation is the process of looking for clues that will give you enough confidence to match records together from different sources. Rarely is one clue enough you give you sufficient confidence. Similarly, some clues are more important than others.
READ MORE

Kymriah and the Outcomes-Based Contract: Is this a Trend?

Is the outcomes based contract agreed for Kymriah the beginning of a trend? The one-time drug has a hefty price tag of $475,000, but Novartis will only receive payment from CMS if patients show significant improvement. Are these contracts a good way of sharing risk and ensuring wider access to novel therapies?
READ MORE

The Myth of Data Permanence

Data Really Isn’t Permanent Cyber specialists warn that once something appears on the Internet, it’s there forever. That’s probably truer for salacious photos of pop stars than it is for corporate or government data, though. In scientific communications, unless you collect data as it’s published, you may not be able to retrieve the information you want when you need it.
READ MORE

Dedicated Field Medical Metrics

Historically, Medical Affairs has primarily served a supportive role. Today, it’s becoming a strategic advantage. Filtering information and experts helps Field Medical teams reduce their preparation time up to an estimated 75 percent, to maximize valuable resources.
READ MORE

CITATION: PD-L1/PD-1 Inhibitors and Beyond

A peer-reviewed article that appeared in the Journal of Pharmacology and Clinical Research by David Segarnick, PhD and Heather Chien, M.S., explores the current and future landscape of immunotherapy compounds that use the body's own immune system to fight cancer, citing Medmeme data
READ MORE

Strategic Metrics Dedicated to Medical Affairs

Metrics that bridge the gap to Medical Affairs 2.0-Historically, decisions for the generation and placement of Medical Affairs data were based on experience and instinct simply because hard, objective information was not available and end-to-end metrics for evaluation simply did not exist. Medical Affairs is in the process of evolving from a traditional support role into a more strategic one that requires a dedicated set of data and analytics
READ MORE

PRESS: Harnessing the Unrivaled Power of Key Opinion Leaders

This month's Pharmaceutical Market Europe Magazine features a thought leadership article from Medmeme.  The article discusses the importance of Medical Affairs engaging thought leaders and KOLs early  - not waiting until phase III trials - to drive Share of Scientific Voice and successful launches.
READ MORE

Are You Being Heard?

Is it better for your scientific paper to appear in JAMA or the New England Journal of Medicine? Should you present your research at a specialty meeting like the Annual Meeting of the Society for Immunotherapy of Cancer or choose a more general conference like the American Society of Clinical Oncology (ASCO)? How you answer those questions affects the impact of your scientific dissemination – your ability to present information to key thought leaders and receive attention from the scientific community.
READ MORE

Never Gonna Give You Up

One thing that data providers are quickly finding out is that maintaining complete, compliant and updated information on Scientific Experts is hard, especially at an enterprise level for a Medical Affairs organization
READ MORE

PRESS: A World of Content, In Context

Medmeme has been featured this week in GEN – Genetic Engineering and Biotechnology News! An in-depth interview with Medmeme’s CEO, Mahesh Naithani, who describes the particular challenges the pharmaceutical industry has in terms of accessing the right data
READ MORE

Big data’s big potential

As the ocean of data gathered from research studies, wearables and medtech continues to spiral, the pharma industry is faced with a conundrum: what data are actually relevant, how can we access them easily and how do we draw insights from them?
READ MORE

Not all data is relevant

Not all data is relevant—in fact, most of it isn’t. Recognizing the fit between the data sources, the analytic tools, and the problem you want to solve is paramount.
READ MORE

Why Context Is Critical

Data without context can’t tell you about trends, can’t help you identify patterns and can’t help you make relative assessments to base your decisions on.
READ MORE

Data Normalization

We have previously discussed the challenging process of disambiguation and its importance to developing a high value database that easily yields trustworthy and consistent results. Yet despite all the complexity and work involved in disambiguation, it only gets you part of the way to clean and useful data. The other critical process is called normalization.
READ MORE

How is Disambiguation Done?

Disambiguation is the process of looking for clues that will give you enough confidence to match records together from different sources. Rarely is one clue enough you give you sufficient confidence. Similarly, some clues are more important than others.
READ MORE
Medmeme Logo
1359 Broadway, Suite 600
New York, NY 10018
Ⓒ Medmeme, LLC 2017. ALL RIGHTS RESERVED